Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy

W Zhao, R Che, S Shang, C Wu, C Li, L Wu, J Chen… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Chinese patients largely experience acute ischemic stroke (AIS)
because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is …

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

W Zhao, R Che, S Shang, C Wu, C Li, L Wu… - Stroke, 2017 - pubmed.ncbi.nlm.nih.gov
Background and purpose Chinese patients largely experience acute ischemic stroke (AIS)
because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is …

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

W Zhao, R Che, S Shang, C Wu, C Li, L Wu, J Chen… - Stroke, 2017 - ingentaconnect.com
Background and Purpose—Chinese patients largely experience acute ischemic stroke (AIS)
because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is …

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

W Zhao, R Che, S Shang, C Wu, C Li, L Wu, J Chen… - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Chinese patients largely experience acute ischemic stroke (AIS)
because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is …

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.

W Zhao, R Che, S Shang, C Wu, C Li, L Wu, J Chen… - Stroke, 2017 - europepmc.org
Background and purpose Chinese patients largely experience acute ischemic stroke (AIS)
because of large artery atherosclerosis rather than cardioembolism, and whether tirofiban is …